Regarding the melanoma stage, both HIF-1a and HIF-2a presented statistically significant higher levels in the patients with advanced melanoma, while the HIF-1a/HIF-2a ratio significantly decreased in patients with high melanoma stages (Table 7). This evidence concerns the gene EPAS1 and melanoma.